There is an increasing body of research suggesting that sulforaphane has a protective effect against Alzheimer’s disease (AD) through mitigating neuroinflammation, tau hyperphosphorylation, amyloid-β accumulation, and oxidative stress in vivo and in vitro models (Table 1). Here, MAPT is linked to Alzheimer disease.